Copyright
©The Author(s) 2016.
World J Hepatol. Jun 18, 2016; 8(17): 716-725
Published online Jun 18, 2016. doi: 10.4254/wjh.v8.i17.716
Published online Jun 18, 2016. doi: 10.4254/wjh.v8.i17.716
HBV and HBV proteins | Innate immune cells, molecules and signaling pathways | Ref. |
HBs | TLR, ISG, IRF3, IFN-β and NF-κB | [20] |
KCs, LSECs, IFN-γ, ISGs, MAPKs, TLR3 | [21] | |
JNK/MAPK, κBα | [24,25,87] | |
mDCs, pDCs, TLR-9 | [42,43] | |
HBe | Hepatocytes, KCs, PBMCs, and TLR2, ISG, IRF3, IFN-β and NF-κB | [20,22] |
TRAM, Mal, TLR2, and TIR:TIR | [28] | |
NF-κB and IFN-β promoter, IFN-γ | [29,62] | |
RIPK2 | [83] | |
HBx | TRIF, RIG-I/MDA5, VISA, MAVS, NF-κB | [31-33,82] |
NEMO, TBK1, IKKi, and IRF3 | [75] | |
HBV Pol | RIG-I, DDX3, NEMO-Cdc37/Hsp90β | [35,36,81] |
TBK1/IKKi, STAT1, PP2A, STING | [32,33,36,76,77,80] | |
HBV | NK, NKG2D, NKG2A, CD16, NKp30, and NKp46 | [56,58,59] |
pDC–NK, NKT | [63,72] | |
CTHRC1 | [84] |
- Citation: Zou ZQ, Wang L, Wang K, Yu JG. Innate immune targets of hepatitis B virus infection. World J Hepatol 2016; 8(17): 716-725
- URL: https://www.wjgnet.com/1948-5182/full/v8/i17/716.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i17.716